Emily P. McQuarrie

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging

Rajan K. Patel, Scott Oliver, Patrick B. Mark et al. · Clinical Journal of the American Society of Nephrology · 2009 · 93 citations · Full text

Demonstration of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary Aldosteronism

E. Marie Freel, Patrick B. Mark, Robin A.P. Weir et al. · Circulation Cardiovascular Imaging · 2012 · 86 citations

Risk factors for bleeding complications after nephrologist-performed native renal biopsy

Jennifer S. Lees, Emily P. McQuarrie, Natalie Mordi et al. · Clinical Kidney Journal · 2017 · 82 citations · Full text